Skip to main content
Top
Published in: The journal of nutrition, health & aging 5/2021

01-05-2021 | SARS-CoV-2

The Impact of Frailty on COVID-19 Outcomes: A Systematic Review and Meta-analysis of 16 Cohort Studies

Authors: Y. Yang, K. Luo, Y. Jiang, Q. Yu, X. Huang, J. Wang, Nanhai Liu, Pan Huang

Published in: The journal of nutrition, health & aging | Issue 5/2021

Login to get access

Abstract

Background

Frail patients are increasingly vulnerable to stress, which is mainly manifested by a reduced physiologic reserve in metabolic and immune systems and neuromuscular system. Several studies found a significant association of frailty with COVID-19 severity to support the evidence for the application of frailty assessment. However, there were contradictory results in other studies. Thus we conducted a systematic review and meta-analysis to synthesize the current studies to investigate impact of frailty on COVID-19 outcomes and provide evidence-based decisions in clinical practice.

Objective

We aimed to synthesize the current studies to investigate impact of frailty on COVID-19 outcomes and provide evidence-based decisions in clinical practice.

Design

A systematic review and Meta-analysis of 16 cohort studies.

Participants

Patients with COVID-19.

Methods

A systematic retrieving for potential literature was conducted in several public electronic databases, including Medline(OvidSP), EMBASE, Pubmed and Chinese databases(China National Knowledge Infrastructure, Wanfang and Weipu) on August 1, 2020. The literature research was updated on October 26, 2020. Newcastle Ottawa Scale for cohort studies was used for quality assessment. RevMan (Version 5.3) and Stata 14.0 were used to synthesize the pooled effects.

Results

According to the predefined inclusion and exclusion criteria, sixteen studies of 4324 patients were included in the final analysis. Frailty was significantly associated with increased risk of all-cause mortality among patients with COVID-19, with pooled adjusted odds ratios of 1.81 (95% confidence intervals:1.48,2.21, I2=87.0%, P<0.001). The result was consistent in stratified analysis to according to age, patient source, definitions of frailty, study quality, and adjustment method. Frailty was significant associated with an increased risk of COVID-19 severity, admission to intensive care unit, application of invasive mechanical ventilation, long-length stay.

Conclusions

In this meta-analysis, we found frailty was significantly associated with an increased risk of clinical adverse events (all- cause mortality, COVID-19 severity, admission to the intensive care unit, application of invasive mechanical ventilation, long-length stay). Given the epidemic of COVID-19 and shortage of medical resources, paying more attention to screening frailty would contribute to disease management and resource allocation among patients with COVID-19.
Appendix
Available only for authorised users
Literature
1.
3.
go back to reference Severin R, Arena R, Lavie CJ et al. Respiratory Muscle Performance Screening for Infectious Disease Management Following COVID-19: A Highly Pressurized Situation. Am J Med 2020; 133(9) 1025–1032.PubMedPubMedCentralCrossRef Severin R, Arena R, Lavie CJ et al. Respiratory Muscle Performance Screening for Infectious Disease Management Following COVID-19: A Highly Pressurized Situation. Am J Med 2020; 133(9) 1025–1032.PubMedPubMedCentralCrossRef
4.
go back to reference Zhu Y, Xie J, Huang F et al. Association between short-term exposure to air pollution and COVID-19 infection: Evidence from China. Sci Total Environ 2020; 727: 138704.PubMedPubMedCentralCrossRef Zhu Y, Xie J, Huang F et al. Association between short-term exposure to air pollution and COVID-19 infection: Evidence from China. Sci Total Environ 2020; 727: 138704.PubMedPubMedCentralCrossRef
5.
go back to reference Brook RD, Levy P, Rajagopalan S. Cardiometabolic Risk Factor Control During Times of Crises and Beyond. Circ Cardiovasc Qual Outcomes 2020; 13(7):006815.CrossRef Brook RD, Levy P, Rajagopalan S. Cardiometabolic Risk Factor Control During Times of Crises and Beyond. Circ Cardiovasc Qual Outcomes 2020; 13(7):006815.CrossRef
6.
go back to reference Brenner EJ, Ungaro RC, Gearry RB et al. Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry. Gastroenterology 2020; 159(2):481–491.PubMedCrossRef Brenner EJ, Ungaro RC, Gearry RB et al. Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry. Gastroenterology 2020; 159(2):481–491.PubMedCrossRef
7.
go back to reference Liang W, Liang H, Ou L et al. Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19. JAMA Intern Med 2020; 180(8):1081–1089.PubMedCrossRef Liang W, Liang H, Ou L et al. Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19. JAMA Intern Med 2020; 180(8):1081–1089.PubMedCrossRef
8.
9.
go back to reference Zhou J, Huang P, Liu P et al. Association of vitamin D deficiency and frailty: A systematic review and meta-analysis. Maturitas 2016; 94: 70–76.PubMedCrossRef Zhou J, Huang P, Liu P et al. Association of vitamin D deficiency and frailty: A systematic review and meta-analysis. Maturitas 2016; 94: 70–76.PubMedCrossRef
10.
go back to reference Kojima G. Frailty as a Predictor of Future Falls Among Community-Dwelling Older People: A Systematic Review and Meta-Analysis. J Am Med Dir Assoc 2015; 16(12):1027–1033.PubMedCrossRef Kojima G. Frailty as a Predictor of Future Falls Among Community-Dwelling Older People: A Systematic Review and Meta-Analysis. J Am Med Dir Assoc 2015; 16(12):1027–1033.PubMedCrossRef
11.
go back to reference Muscedere J, Waters B, Varambally A et al. The impact of frailty on intensive care unit outcomes: a systematic review and meta-analysis. Intensive Care Med. 2017; 43(8): 1105–1122.PubMedPubMedCentralCrossRef Muscedere J, Waters B, Varambally A et al. The impact of frailty on intensive care unit outcomes: a systematic review and meta-analysis. Intensive Care Med. 2017; 43(8): 1105–1122.PubMedPubMedCentralCrossRef
12.
go back to reference Cunha AIL, Veronese N, de Melo Borges S et al. Frailty as a predictor of adverse outcomes in hospitalized older adults: A systematic review and meta-analysis. Ageing Res Rev 2019; 56:100960.PubMedCrossRef Cunha AIL, Veronese N, de Melo Borges S et al. Frailty as a predictor of adverse outcomes in hospitalized older adults: A systematic review and meta-analysis. Ageing Res Rev 2019; 56:100960.PubMedCrossRef
13.
go back to reference Kojima G, Iliffe S, Taniguchi Y et al. Prevalence of frailty in Japan: A systematic review and meta-analysis. J Epidemiol 2017; 27(8):347–353.PubMedCrossRef Kojima G, Iliffe S, Taniguchi Y et al. Prevalence of frailty in Japan: A systematic review and meta-analysis. J Epidemiol 2017; 27(8):347–353.PubMedCrossRef
14.
go back to reference Kojima G. Prevalence of Frailty in Nursing Homes: A Systematic Review and Meta-Analysis. J Am Med Dir Assoc; 2015. 16(11): 940–945.PubMedCrossRef Kojima G. Prevalence of Frailty in Nursing Homes: A Systematic Review and Meta-Analysis. J Am Med Dir Assoc; 2015. 16(11): 940–945.PubMedCrossRef
15.
go back to reference Houghton JSM, Nickinson ATO, Morton AJ et al. Frailty Factors and Outcomes in Vascular Surgery Patients: A Systematic Review and Meta-analysis. Ann Surg; 2019. Houghton JSM, Nickinson ATO, Morton AJ et al. Frailty Factors and Outcomes in Vascular Surgery Patients: A Systematic Review and Meta-analysis. Ann Surg; 2019.
16.
go back to reference Houghton JSM, Nickinson ATO, Morton AJ et al. Frailty Factors and Outcomes in Vascular Surgery Patients: A Systematic Review and Meta-analysis. Ann Surg 2020; 272(2): 266–276.PubMedCrossRef Houghton JSM, Nickinson ATO, Morton AJ et al. Frailty Factors and Outcomes in Vascular Surgery Patients: A Systematic Review and Meta-analysis. Ann Surg 2020; 272(2): 266–276.PubMedCrossRef
17.
go back to reference Shen HQ, Wu B, Xie HP et al. Preparation of Axially Chiral 2,2’-Biimidazole Ligands through Remote Chirality Delivery and Their Application in Asymmetric Carbene Insertion into N-H of Carbazoles. Org Lett 2019; 21(8): 2712–2717.PubMedCrossRef Shen HQ, Wu B, Xie HP et al. Preparation of Axially Chiral 2,2’-Biimidazole Ligands through Remote Chirality Delivery and Their Application in Asymmetric Carbene Insertion into N-H of Carbazoles. Org Lett 2019; 21(8): 2712–2717.PubMedCrossRef
18.
go back to reference Yang X, Lupón J, Vidán MT et al. Impact of Frailty on Mortality and Hospitalization in Chronic Heart Failure: A Systematic Review and Meta-Analysis. J Am Heart Assoc 2018; 7(23):e008251.PubMedPubMedCentralCrossRef Yang X, Lupón J, Vidán MT et al. Impact of Frailty on Mortality and Hospitalization in Chronic Heart Failure: A Systematic Review and Meta-Analysis. J Am Heart Assoc 2018; 7(23):e008251.PubMedPubMedCentralCrossRef
19.
go back to reference Hewitt J, Long S, Carter B et al. The prevalence of frailty and its association with clinical outcomes in general surgery: a systematic review and meta-analysis. Age Ageing 2018; 47(6): 793–800.PubMedCrossRef Hewitt J, Long S, Carter B et al. The prevalence of frailty and its association with clinical outcomes in general surgery: a systematic review and meta-analysis. Age Ageing 2018; 47(6): 793–800.PubMedCrossRef
20.
go back to reference Kusumastuti S, Rozing MP, Lund R et al. The added value of health indicators to mortality predictions in old age: A systematic review. Eur J Intern Med 2018; 57: 7–18.PubMedCrossRef Kusumastuti S, Rozing MP, Lund R et al. The added value of health indicators to mortality predictions in old age: A systematic review. Eur J Intern Med 2018; 57: 7–18.PubMedCrossRef
21.
22.
go back to reference Tandon P, Tangri N, Thomas L et al. A Rapid Bedside Screen to Predict Unplanned Hospitalization and Death in Outpatients With Cirrhosis: A Prospective Evaluation of the Clinical Frailty Scale. Am J Gastroenterol 2016; 111(12): 1759–1767.PubMedCrossRef Tandon P, Tangri N, Thomas L et al. A Rapid Bedside Screen to Predict Unplanned Hospitalization and Death in Outpatients With Cirrhosis: A Prospective Evaluation of the Clinical Frailty Scale. Am J Gastroenterol 2016; 111(12): 1759–1767.PubMedCrossRef
23.
go back to reference Labenz C, Kremer WM, Schattenberg JM et al. Clinical Frailty Scale for risk stratification in patients with SARS-CoV-2 infection. J Investig Med 2020; 68(6): 1199–1202.PubMedPubMedCentralCrossRef Labenz C, Kremer WM, Schattenberg JM et al. Clinical Frailty Scale for risk stratification in patients with SARS-CoV-2 infection. J Investig Med 2020; 68(6): 1199–1202.PubMedPubMedCentralCrossRef
25.
go back to reference Han SA, KochVG. Clinical and Ethical Considerations in Allocation of Ventilators in an Influenza Pandemic or Other Public Health Disaster: A Comparison of the 2007 and 2015 New York State Ventilator Allocation Guidelines. Disaster Med Public Health Prep 2020;1–10. Han SA, KochVG. Clinical and Ethical Considerations in Allocation of Ventilators in an Influenza Pandemic or Other Public Health Disaster: A Comparison of the 2007 and 2015 New York State Ventilator Allocation Guidelines. Disaster Med Public Health Prep 2020;1–10.
26.
go back to reference Hewitt J, Carter B, Vilches-Moraga A et al. The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study. Lancet Public Health 2020; 5(8):444–451.CrossRef Hewitt J, Carter B, Vilches-Moraga A et al. The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study. Lancet Public Health 2020; 5(8):444–451.CrossRef
27.
go back to reference Chinnadurai R, Ogedengbe O, Agarwal P et al. Older age and frailty are the chief predictors of mortality in COVID-19 patients admitted to an acute medical unit in a secondary care setting- a cohort study. BMC Geriatr 2020; 20(1): 409.PubMedPubMedCentralCrossRef Chinnadurai R, Ogedengbe O, Agarwal P et al. Older age and frailty are the chief predictors of mortality in COVID-19 patients admitted to an acute medical unit in a secondary care setting- a cohort study. BMC Geriatr 2020; 20(1): 409.PubMedPubMedCentralCrossRef
28.
go back to reference Knopp P, Miles A, Webb TE et al. Presenting features of COVID-19 in older people: relationships with frailty, inflammation and mortality. Eur Geriatr Med 2020; 1–6. Knopp P, Miles A, Webb TE et al. Presenting features of COVID-19 in older people: relationships with frailty, inflammation and mortality. Eur Geriatr Med 2020; 1–6.
29.
go back to reference Darvall JN, Bellomo R, Bailey M et al. Frailty and outcomes from pneumonia in critical illness: a population-based cohort study. Br J Anaesth 2020; 125(5): 730–738.PubMedCrossRef Darvall JN, Bellomo R, Bailey M et al. Frailty and outcomes from pneumonia in critical illness: a population-based cohort study. Br J Anaesth 2020; 125(5): 730–738.PubMedCrossRef
30.
go back to reference Pan L, Huang P, Xie X et al. Metabolic associated fatty liver disease increases the severity of COVID-19: A meta-analysis. Dig Liver Dis 2020. Pan L, Huang P, Xie X et al. Metabolic associated fatty liver disease increases the severity of COVID-19: A meta-analysis. Dig Liver Dis 2020.
31.
go back to reference Willi C, Bodenmann P, Ghali WA et al. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. Jama 2007; 298(22): 2654–2664.PubMedCrossRef Willi C, Bodenmann P, Ghali WA et al. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. Jama 2007; 298(22): 2654–2664.PubMedCrossRef
32.
go back to reference Pourbaix A, Lafont Rapnouil B, Guéry R et al. Smoking as a Risk Factor of Invasive Fungal Disease: Systematic Review and Meta-Analysis. Clin Infect Dis 2020; 71(4): 1106–1119.PubMedCrossRef Pourbaix A, Lafont Rapnouil B, Guéry R et al. Smoking as a Risk Factor of Invasive Fungal Disease: Systematic Review and Meta-Analysis. Clin Infect Dis 2020; 71(4): 1106–1119.PubMedCrossRef
33.
go back to reference Zhang Y, Fang F, Tang J et al. Association between vitamin D supplementation and mortality: systematic review and meta-analysis. Bmj 2019; 366:14673. Zhang Y, Fang F, Tang J et al. Association between vitamin D supplementation and mortality: systematic review and meta-analysis. Bmj 2019; 366:14673.
34.
go back to reference Kundi H, Çetin EhÖ, Canpolat U et al. The role of Frailty on Adverse Outcomes Among Older Patients with COVID-19. J Infect 2020. Kundi H, Çetin EhÖ, Canpolat U et al. The role of Frailty on Adverse Outcomes Among Older Patients with COVID-19. J Infect 2020.
35.
go back to reference Steinmeyer Z, Vienne-Noyes S, Bernard M et al. Acute Care of Older Patients with COVID-19: Clinical Characteristics and Outcomes. Geriatrics (Basel) 2020; 5(4). Steinmeyer Z, Vienne-Noyes S, Bernard M et al. Acute Care of Older Patients with COVID-19: Clinical Characteristics and Outcomes. Geriatrics (Basel) 2020; 5(4).
36.
go back to reference Shi SM, Bakaev I, Chen H et al. Risk Factors, Presentation, and Course of Coronavirus Disease 2019 in a Large, Academic Long-Term Care Facility. J Am Med Dir Assoc 2020; 21(10): 1378–1383.PubMedPubMedCentralCrossRef Shi SM, Bakaev I, Chen H et al. Risk Factors, Presentation, and Course of Coronavirus Disease 2019 in a Large, Academic Long-Term Care Facility. J Am Med Dir Assoc 2020; 21(10): 1378–1383.PubMedPubMedCentralCrossRef
37.
go back to reference Hägg S, Jylhävä J, Wang, Y et al. Age, Frailty, and Comorbidity as Prognostic Factors for Short-Term Outcomes in Patients With Coronavirus Disease 2019 in Geriatric Care. J Am Med Dir Assoc 2020. Hägg S, Jylhävä J, Wang, Y et al. Age, Frailty, and Comorbidity as Prognostic Factors for Short-Term Outcomes in Patients With Coronavirus Disease 2019 in Geriatric Care. J Am Med Dir Assoc 2020.
38.
go back to reference Maguire D, Woods M, Richards C et al. Prognostic factors in patients admitted to an urban teaching hospital with COVID-19 infection. J Transl Med 2020; 18(1): 354.PubMedPubMedCentralCrossRef Maguire D, Woods M, Richards C et al. Prognostic factors in patients admitted to an urban teaching hospital with COVID-19 infection. J Transl Med 2020; 18(1): 354.PubMedPubMedCentralCrossRef
39.
go back to reference Marengoni A, Zucchelli A, Grande G et al. The impact of delirium on outcomes for older adults hospitalised with COVID-19. Age Ageing 2020. Marengoni A, Zucchelli A, Grande G et al. The impact of delirium on outcomes for older adults hospitalised with COVID-19. Age Ageing 2020.
40.
go back to reference Aw D, Woodrow L, Ogliari G et al. Association of Frailty with Mortality in Older Inpatients with Covid-19: A Cohort Study. Age Ageing 2020. Aw D, Woodrow L, Ogliari G et al. Association of Frailty with Mortality in Older Inpatients with Covid-19: A Cohort Study. Age Ageing 2020.
41.
go back to reference Owen RK, Conroy SP, Taub N et al. Comparing associations between frailty and mortality in hospitalised older adults with or without COVID-19 infection: a retrospective observational study using electronic health records. Age Ageing 2020. Owen RK, Conroy SP, Taub N et al. Comparing associations between frailty and mortality in hospitalised older adults with or without COVID-19 infection: a retrospective observational study using electronic health records. Age Ageing 2020.
42.
go back to reference Fiorentino M, Pentakota SR, Mosenthal AC et al. The Palliative Performance Scale predicts mortality in hospitalized patients with COVID-19. Palliat Med 2020; 34(9): 1228–1234.PubMedPubMedCentralCrossRef Fiorentino M, Pentakota SR, Mosenthal AC et al. The Palliative Performance Scale predicts mortality in hospitalized patients with COVID-19. Palliat Med 2020; 34(9): 1228–1234.PubMedPubMedCentralCrossRef
43.
go back to reference De Smet R, Mellaerts B, Vandewinckele H et al. Frailty and Mortality in Hospitalized Older Adults With COVID-19: Retrospective Observational Study. J Am Med Dir Assoc 2020; 21(7): 928–932.PubMedPubMedCentralCrossRef De Smet R, Mellaerts B, Vandewinckele H et al. Frailty and Mortality in Hospitalized Older Adults With COVID-19: Retrospective Observational Study. J Am Med Dir Assoc 2020; 21(7): 928–932.PubMedPubMedCentralCrossRef
44.
go back to reference Burns GP, Lane ND, Tedd HM et al. Improved survival following ward-based non-invasive pressure support for severe hypoxia in a cohort of frail patients with COVID-19: retrospective analysis from a UK teaching hospital. BMJ Open Respir Res 2020; 7(1). Burns GP, Lane ND, Tedd HM et al. Improved survival following ward-based non-invasive pressure support for severe hypoxia in a cohort of frail patients with COVID-19: retrospective analysis from a UK teaching hospital. BMJ Open Respir Res 2020; 7(1).
45.
go back to reference Rawle MJ, Bertfield DL, Brill SE. Atypical presentations of COVID-19 in care home residents presenting to secondary care: A UK single centre study. Aging Medicine 2020. Rawle MJ, Bertfield DL, Brill SE. Atypical presentations of COVID-19 in care home residents presenting to secondary care: A UK single centre study. Aging Medicine 2020.
46.
go back to reference Ma Y, Hou L, Yang X et al. The association between frailty and severe disease among COVID-19 patients aged over 60 years in China: a prospective cohort study. BMC Med 2020; 18(1):274.PubMedPubMedCentralCrossRef Ma Y, Hou L, Yang X et al. The association between frailty and severe disease among COVID-19 patients aged over 60 years in China: a prospective cohort study. BMC Med 2020; 18(1):274.PubMedPubMedCentralCrossRef
47.
go back to reference Miles A, Webb TE, McLoughlin BC et al. Outcomes from COVID-19 across the range of frailty: excess mortality in fitter older people. Eur Geriatr Med 2020; 11(5):851–855.PubMedPubMedCentralCrossRef Miles A, Webb TE, McLoughlin BC et al. Outcomes from COVID-19 across the range of frailty: excess mortality in fitter older people. Eur Geriatr Med 2020; 11(5):851–855.PubMedPubMedCentralCrossRef
48.
go back to reference Brill SE, Jarvis HC, Ozcan E et al. COVID-19: a retrospective cohort study with focus on the over-80s and hospital-onset disease. BMC Med 2020; 18(1):194.PubMedPubMedCentralCrossRef Brill SE, Jarvis HC, Ozcan E et al. COVID-19: a retrospective cohort study with focus on the over-80s and hospital-onset disease. BMC Med 2020; 18(1):194.PubMedPubMedCentralCrossRef
49.
go back to reference Hoek RAS, Manintveld OC, Betjes MGH et al. COVID-19 in solid organ transplant recipients: a single-center experience. Transpl Int 2020. Hoek RAS, Manintveld OC, Betjes MGH et al. COVID-19 in solid organ transplant recipients: a single-center experience. Transpl Int 2020.
50.
go back to reference Knights H, Mayor N, Millar K et al. Characteristics and outcomes of patients with COVID-19 at a district general hospital in Surrey, UK. Clin Med (Lond) 2020; 20(5):148–153.CrossRef Knights H, Mayor N, Millar K et al. Characteristics and outcomes of patients with COVID-19 at a district general hospital in Surrey, UK. Clin Med (Lond) 2020; 20(5):148–153.CrossRef
51.
go back to reference Woolford SJ, D’Angelo S, Curtis EM et al. COVID-19 and associations with frailty and multimorbidity: a prospective analysis of UK Biobank participants. Aging Clin Exp Res 2020; 32(9):1897–1905.PubMedPubMedCentralCrossRef Woolford SJ, D’Angelo S, Curtis EM et al. COVID-19 and associations with frailty and multimorbidity: a prospective analysis of UK Biobank participants. Aging Clin Exp Res 2020; 32(9):1897–1905.PubMedPubMedCentralCrossRef
52.
go back to reference Dent E, Morley JE, Cruz-Jentoft AJ et al. Physical Frailty: ICFSR International Clinical Practice Guidelines for Identification and Management. J Nutr Health Aging 2019; 23(9):771–787.PubMedPubMedCentralCrossRef Dent E, Morley JE, Cruz-Jentoft AJ et al. Physical Frailty: ICFSR International Clinical Practice Guidelines for Identification and Management. J Nutr Health Aging 2019; 23(9):771–787.PubMedPubMedCentralCrossRef
53.
go back to reference Maltese G, Corsonello A, Di Rosa M et al. Frailty and COVID-19: A Systematic Scoping Review. J Clin Med 2020;9(7). Maltese G, Corsonello A, Di Rosa M et al. Frailty and COVID-19: A Systematic Scoping Review. J Clin Med 2020;9(7).
54.
go back to reference Xu L, Mao Y, Chen G. Risk factors for 2019 novel coronavirus disease (COVID-19) patients progressing to critical illness: a systematic review and meta-analysis. Aging (Albany NY) 2020; 12(12): 12410–12421.CrossRef Xu L, Mao Y, Chen G. Risk factors for 2019 novel coronavirus disease (COVID-19) patients progressing to critical illness: a systematic review and meta-analysis. Aging (Albany NY) 2020; 12(12): 12410–12421.CrossRef
55.
go back to reference Qin JJ, Cheng X, Zhou F et al. Redefining Cardiac Biomarkers in Predicting Mortality of Inpatients With COVID-19. Hypertension 2020; 76(4): 1104–1112.PubMedCrossRef Qin JJ, Cheng X, Zhou F et al. Redefining Cardiac Biomarkers in Predicting Mortality of Inpatients With COVID-19. Hypertension 2020; 76(4): 1104–1112.PubMedCrossRef
56.
go back to reference Crapo RO, Kanner RE, Jensen RL et al. Variability of the single-breath carbon monoxide transfer factor as a function of inspired oxygen pressure. Eur Respir J 1988; 1(6): 573–574.PubMedCrossRef Crapo RO, Kanner RE, Jensen RL et al. Variability of the single-breath carbon monoxide transfer factor as a function of inspired oxygen pressure. Eur Respir J 1988; 1(6): 573–574.PubMedCrossRef
57.
go back to reference Hoffmann M, Kleine-Weber H, Schroeder S et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 2020; 181(2): 271–280.PubMedPubMedCentralCrossRef Hoffmann M, Kleine-Weber H, Schroeder S et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 2020; 181(2): 271–280.PubMedPubMedCentralCrossRef
58.
go back to reference Tipnis SR, Hooper NM, Hyde R et al. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 2000; 275(43):33238–33243.PubMedCrossRef Tipnis SR, Hooper NM, Hyde R et al. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 2000; 275(43):33238–33243.PubMedCrossRef
60.
go back to reference Potere N, Valeriani E, Candeloro M et al. Acute complications and mortality in hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis. Crit Care 2020; 24(1):389.PubMedPubMedCentralCrossRef Potere N, Valeriani E, Candeloro M et al. Acute complications and mortality in hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis. Crit Care 2020; 24(1):389.PubMedPubMedCentralCrossRef
61.
go back to reference Ahmed J, Rizwan T, Malik F et al. COVID-19 and Liver Injury: A Systematic Review and Meta-Analysis. Cureus 2020; 12(7): 9424. Ahmed J, Rizwan T, Malik F et al. COVID-19 and Liver Injury: A Systematic Review and Meta-Analysis. Cureus 2020; 12(7): 9424.
62.
go back to reference Yang X, Jin Y, Li R et al. Prevalence and impact of acute renal impairment on COVID-19: a systematic review and meta-analysis. Crit Care 2020; 24(1): 356.PubMedPubMedCentralCrossRef Yang X, Jin Y, Li R et al. Prevalence and impact of acute renal impairment on COVID-19: a systematic review and meta-analysis. Crit Care 2020; 24(1): 356.PubMedPubMedCentralCrossRef
63.
go back to reference Gilbert T, Neuburger J, Kraindler J et al. Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care settings using electronic hospital records: an observational study. Lancet 2018; 391(10132): 1775–1782.PubMedPubMedCentralCrossRef Gilbert T, Neuburger J, Kraindler J et al. Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care settings using electronic hospital records: an observational study. Lancet 2018; 391(10132): 1775–1782.PubMedPubMedCentralCrossRef
64.
go back to reference Liu PP, Blet A, Smyth D et al. The Science Underlying COVID-19: Implications for the Cardiovascular System. Circulation 2020; 142(1):68–78.PubMedCrossRef Liu PP, Blet A, Smyth D et al. The Science Underlying COVID-19: Implications for the Cardiovascular System. Circulation 2020; 142(1):68–78.PubMedCrossRef
65.
go back to reference Guo T, Shen Q, Guo W et al. Clinical Characteristics of Elderly Patients with COVID-19 in Hunan Province, China: A Multicenter, Retrospective Study. Gerontology 2020; 66(5): 467–475.PubMedCrossRef Guo T, Shen Q, Guo W et al. Clinical Characteristics of Elderly Patients with COVID-19 in Hunan Province, China: A Multicenter, Retrospective Study. Gerontology 2020; 66(5): 467–475.PubMedCrossRef
66.
go back to reference Zhao M, Wang M, Zhang J et al. Comparison of clinical characteristics and outcomes of patients with coronavirus disease 2019 at different ages. Aging (Albany NY) 2020; 12(11):10070–10086.CrossRef Zhao M, Wang M, Zhang J et al. Comparison of clinical characteristics and outcomes of patients with coronavirus disease 2019 at different ages. Aging (Albany NY) 2020; 12(11):10070–10086.CrossRef
67.
go back to reference Guan W.J, Liang WH, Zhao Y et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J 2020; 55(5). Guan W.J, Liang WH, Zhao Y et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J 2020; 55(5).
68.
go back to reference Pansarasa O, Pistono C, Davin A et al. Altered immune system in frailty: Genetics and diet may influence inflammation. Ageing Res Rev 2019; 54: 100935.PubMedCrossRef Pansarasa O, Pistono C, Davin A et al. Altered immune system in frailty: Genetics and diet may influence inflammation. Ageing Res Rev 2019; 54: 100935.PubMedCrossRef
69.
70.
go back to reference Soysal P, Stubbs B, Lucato P et al. Inflammation and frailty in the elderly: A systematic review and meta-analysis. Ageing Res Rev 2016; 31:1–8.PubMedCrossRef Soysal P, Stubbs B, Lucato P et al. Inflammation and frailty in the elderly: A systematic review and meta-analysis. Ageing Res Rev 2016; 31:1–8.PubMedCrossRef
71.
go back to reference Dent E, Martin FC, Bergman H et al. Management of frailty: opportunities, challenges, and future directions. Lancet 2019; 394(10206): 1376–1386.PubMedCrossRef Dent E, Martin FC, Bergman H et al. Management of frailty: opportunities, challenges, and future directions. Lancet 2019; 394(10206): 1376–1386.PubMedCrossRef
72.
go back to reference Doglietto F, Vezzoli M, Gheza F et al. Factors Associated With Surgical Mortality and Complications Among Patients With and Without Coronavirus Disease 2019 (COVID-19) in Italy. JAMA Surg 2020; 155(8): 1–14.PubMedCentralCrossRef Doglietto F, Vezzoli M, Gheza F et al. Factors Associated With Surgical Mortality and Complications Among Patients With and Without Coronavirus Disease 2019 (COVID-19) in Italy. JAMA Surg 2020; 155(8): 1–14.PubMedCentralCrossRef
73.
go back to reference Hardy RJ, Thompson SG. Detecting and describing heterogeneity in meta-analysis. Stat Med 1998; 17(8): 841–856.PubMedCrossRef Hardy RJ, Thompson SG. Detecting and describing heterogeneity in meta-analysis. Stat Med 1998; 17(8): 841–856.PubMedCrossRef
Metadata
Title
The Impact of Frailty on COVID-19 Outcomes: A Systematic Review and Meta-analysis of 16 Cohort Studies
Authors
Y. Yang
K. Luo
Y. Jiang
Q. Yu
X. Huang
J. Wang
Nanhai Liu
Pan Huang
Publication date
01-05-2021
Publisher
Springer Paris
Published in
The journal of nutrition, health & aging / Issue 5/2021
Print ISSN: 1279-7707
Electronic ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-021-1611-9

Other articles of this Issue 5/2021

The journal of nutrition, health & aging 5/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.